Rx Only

Ready for 24-48h Central Dispatch

In Stock

S-KRAL Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download

SyrupPrescription Required (Schedule Drug)

S-KRAL

Name: S-KRAL
Brand: Sygnus Biotech

Active Drug Composition

Oxetacaine 20mg + Sucralfate 1gm

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

S-KRAL is an advanced gastro-protective formulation developed for the rapid healing of mucosal erosion, acid peptic disorders, and gastroesophageal reflux disease (GERD).

Dosage FormOral Liquid Suspension / Syrup

Packaging Presentation100ml / 200ml PET Bottle with Graduated Measuring Cap

B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Peptic Ulcer Disease

Duodenal Ulcers

Acid Reflux & GERD

Gastritis & Mucosal Inflammation

Stress Ulcer Prophylaxis

Mechanism of Action (MOA)

Forms a polyanionic protective barrier coating over inflamed gastric ulcers, preventing enzymatic acid degradation while facilitating tissue re-epithelialization.

Dosage & Posology

Administer on an empty stomach 1 hour before principal meals, or as posology prescribed by the gastroenterologist.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup

Dosage FormOral Liquid Suspension / Syrup

Packaging Type100ml / 200ml PET Bottle with Graduated Measuring Cap

Regulatory ScheduleSchedule H

Minimum Order Qty100 Units

Country of OriginIndia (Sidhpur Facility)

Quality StandardWHO-GMP & ISO 9001:2015

Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

S-KRAL features Oxetacaine 20mg + Sucralfate 1gm prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup

Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of S-KRAL

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.

Distributor Inquiries

Questions Regarding S-KRAL

What is the therapeutic indication and composition of S-KRAL?

S-KRAL contains Oxetacaine 20mg + Sucralfate 1gm indicated for Peptic Ulcer Disease as formulated by Sygnus Biotech.

What packaging presentations are available for S-KRAL?

S-KRAL is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for S-KRAL?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for S-KRAL along with promotional visual aids, product cards, and marketing support.